A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults
Running, not enrolling · Phase 3
Conditions studied: Respiratory Syncytial Virus
In brief
The study is divided into 2 parts (Part A and Part B). Part A of the study will evaluate the safety and immune response to mRNA-1345 in high-risk adults aged ≥18 to \<60 years. Part B of the study will evaluate the safety and immune response to mRNA-1345 in adults who received solid organ transplant (SOT).
Key facts
- Study ID
- NCT06067230
- Run by
- ModernaTX, Inc.
- People needed
- 1153
- Starts
- 2023-10-06
- Expected to finish
- 2026-07-30
- Last updated by the study team
- 2025-08-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Lenzmeier Family Medicine - CCT - PPDS — Glendale, Arizona, United States
- Foothills Research Center - CCT - PPDS — Phoenix, Arizona, United States
- Fiel Family & Sports Medicine - PC - CCT - PPDS — Tempe, Arizona, United States
- Baptist Health Center for Clinical Research — Little Rock, Arkansas, United States
- David Geffen School of Medicine at UCLA — Los Angeles, California, United States
- Artemis Institute For Clinical Research LLC - San Diego - Headlands - PPDS — San Diego, California, United States
- Critical Care, Pulmonary and Sleep Associates / CCT Research — Lakewood, Colorado, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- Excel Medical Clinical Trials DBA Flourish — Boca Raton, Florida, United States
- Indago Research and Health Center — Hialeah, Florida, United States
- CenExel RCA - Hollywood — Hollywood, Florida, United States
- Clinical Research Atlanta - Headlands - PPDS — Stockbridge, Georgia, United States
- Snake River Research, PLLC — Idaho Falls, Idaho, United States
- University of Chicago — Chicago, Illinois, United States
- AES - DRS - Optimal Research Illinois - Peoria — Peoria, Illinois, United States
- Benchmark Research - Covington - HyperCore - PPDS — Covington, Louisiana, United States
- Velocity Clinical Research (Rockville - Maryland) - PPDS — Rockville, Maryland, United States
- Henry Ford Hospital — Detroit, Michigan, United States
- DM Clinical Research - Southfield - ERN - PPDS — Southfield, Michigan, United States
- Velocity Clinical Research (Lincoln - Nebraska) - PPDS — Lincoln, Nebraska, United States
- University of Rochester - Rochester General Hospital - PPDS — Rochester, New York, United States
- Montefiore Medical Center - BRANY - PPDS — The Bronx, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- DM Clinical Research - Philadelphia - ERN - PPDS — Philadelphia, Pennsylvania, United States
- Benchmark Research - Fort Worth - HyperCore - PPDS — Fort Worth, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.